These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 11677369

  • 1. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T.
    J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
    [Abstract] [Full Text] [Related]

  • 2. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Ozawa Y, Saruta T.
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [Abstract] [Full Text] [Related]

  • 3. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Saruta T.
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [Abstract] [Full Text] [Related]

  • 4. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
    Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K.
    Pharmacology; 2006 Sep; 78(1):11-20. PubMed ID: 16899990
    [Abstract] [Full Text] [Related]

  • 5. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.
    Circ Res; 2007 Feb 16; 100(3):342-53. PubMed ID: 17307972
    [Abstract] [Full Text] [Related]

  • 6. Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.
    Hayashi K, Wakino S, Ozawa Y, Homma K, Kanda T, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T.
    Keio J Med; 2005 Jun 16; 54(2):102-8. PubMed ID: 16077260
    [Abstract] [Full Text] [Related]

  • 7. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
    Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T.
    Am J Nephrol; 2003 Jun 16; 23(4):229-44. PubMed ID: 12840599
    [Abstract] [Full Text] [Related]

  • 8. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
    Tanaka H, Shigenobu K.
    Cardiovasc Drug Rev; 2002 Jun 16; 20(1):81-92. PubMed ID: 12070536
    [Abstract] [Full Text] [Related]

  • 9. Disparate effects of calcium antagonists on renal microcirculation.
    Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T.
    Hypertens Res; 1996 Mar 16; 19(1):31-6. PubMed ID: 8829821
    [Abstract] [Full Text] [Related]

  • 10. Vascular effects of calcium channel antagonists: new evidence.
    Richard S.
    Drugs; 2005 Mar 16; 65 Suppl 2():1-10. PubMed ID: 16398057
    [Abstract] [Full Text] [Related]

  • 11. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Wakino S, Saruta T.
    J Cardiovasc Pharmacol; 1999 Feb 16; 33(2):243-7. PubMed ID: 10028932
    [Abstract] [Full Text] [Related]

  • 12. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
    Hayashi K, Wakino S, Homma K, Sugano N, Saruta T.
    J Pharmacol Sci; 2005 Nov 16; 99(3):221-7. PubMed ID: 16293936
    [Abstract] [Full Text] [Related]

  • 13. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E, Van Deusen AL, Vitko I.
    J Pharmacol Exp Ther; 2009 Feb 16; 328(2):621-7. PubMed ID: 18974361
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
    Ball CJ, Wilson DP, Turner SP, Saint DA, Beltrame JF.
    Hypertension; 2009 Apr 16; 53(4):654-60. PubMed ID: 19237682
    [Abstract] [Full Text] [Related]

  • 15. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Hayashi K, Ozawa Y, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Saruta T.
    J Cardiovasc Pharmacol; 2003 Dec 16; 42(6):697-702. PubMed ID: 14639089
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K.
    J Atheroscler Thromb; 2009 Oct 16; 16(5):568-75. PubMed ID: 19749494
    [Abstract] [Full Text] [Related]

  • 17. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
    Feng MG, Li M, Navar LG.
    Am J Physiol Renal Physiol; 2004 Feb 16; 286(2):F331-7. PubMed ID: 14583435
    [Abstract] [Full Text] [Related]

  • 18. A selective T-type Ca2+ channel blocker R(-) efonidipine.
    Shin MC, Kim CJ, Min BI, Ogawa S, Tanaka E, Akaike N.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun 16; 377(4-6):411-21. PubMed ID: 18278483
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
    Imagawa K, Okayama S, Takaoka M, Kawata H, Naya N, Nakajima T, Horii M, Uemura S, Saito Y.
    J Cardiovasc Pharmacol; 2006 Jan 16; 47(1):133-8. PubMed ID: 16424797
    [Abstract] [Full Text] [Related]

  • 20. Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development.
    Tanaka H, Shigenobu K.
    J Pharmacol Sci; 2005 Nov 16; 99(3):214-20. PubMed ID: 16293935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.